NCT04446429Completed
Anti-Androgen Treatment for COVID-19
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Applied Biology, Inc.
- Participants (registry)
- 268
- Start
- October 2020
- Primary completion
- December 2020
- Study completion
- January 2021
- Last registry update
- December 2021
- Countries
- Brazil
Conditions studied: COVID-19, SARS-CoV2, Androgenetic Alopecia, Prostate Cancer, Benign Prostatic Hyperplasia, SARS (Severe Acute Respiratory Syndrome)
Interventions: Proxalutamide, Standard of Care
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.